Shenzhen Zhongke Xinjin Biotechnology
Latest round
- Angel
Last raised
- Nov 2021
Total raised
- $1.6M
Investors
- 4
About Shenzhen Zhongke Xinjin Biotechnology
Based in Shenzhen, China, and established in 2021, Shenzhen Zhongke Xinjin Biotechnology is a peptide drugs developer. The company co-found by Professor Peigen Ren, an expert from the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, and Mr. Liangzheng Qin, who is engaged in the development and production of peptide drug technology. The company developed two product lines, Non-alcoholic steatohepatitis (NASH) and lose weight. Those products used the technology of Metabolitin -GPRC6A-Neurotensin inhibiting the absorption of lipids in the small intestine, and MTL-GPRC6A-GLP-1 regulating blood sugar. The company plans to accelerate the development of the NASH, and lose weight drug, and to complete to apply for investigational new drug (IND) of National Medical Products Administration (NMPA), and Food and Drug Administration (FDA) in 2024. Moreover, it will continue to develop new drug for metabolic diseases and reproductive health.
Who invested in Shenzhen Zhongke Xinjin Biotechnology
4 investors across 1 round
See all investors in Shenzhen Zhongke Xinjin Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Nov 26, 2021
Amount
$1.6M
Investors
Questions about Shenzhen Zhongke Xinjin Biotechnology
Who invested in Shenzhen Zhongke Xinjin Biotechnology?
Shenzhen Zhongke Xinjin Biotechnology has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shenzhen Zhongke Xinjin Biotechnology raised?
Shenzhen Zhongke Xinjin Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Shenzhen Zhongke Xinjin Biotechnology last raise money?
Shenzhen Zhongke Xinjin Biotechnology's most recent round on record is a Angel, in Nov 2021.
What does Shenzhen Zhongke Xinjin Biotechnology do?
Based in Shenzhen, China, and established in 2021, Shenzhen Zhongke Xinjin Biotechnology is a peptide drugs developer.
Where is Shenzhen Zhongke Xinjin Biotechnology headquartered?
Shenzhen Zhongke Xinjin Biotechnology is headquartered in Shenzhen, China.
Which VCs invest in companies like Shenzhen Zhongke Xinjin Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at Shenzhen Zhongke Xinjin Biotechnology's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Angel
Raising like Shenzhen Zhongke Xinjin Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.